SYDNEY (Reuters) - Australia's pharmaceutical regulator said on Thursday it is on course to review Pfizer's COVID-19 vaccine by January 2021, with the country sticking to a March timetable to start vaccinations. Read full story ......Full Article
Australia aims to complete review of Pfizer's COVID-19 vaccine by January 2021
WorldNews0 shares 1 views
Related news coverage
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.’s President, Dr. Anil Diwan
*SHELTON, CT / ACCESSWIRE / **January 27, 2021 /* NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the..